Neil F. McFarlane - 31 Jan 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Neil F. McFarlane
Issuer symbol
ZVRA
Transactions as of
31 Jan 2025
Net transactions value
$0
Form type
4
Filing time
03 Feb 2025, 17:19:31 UTC
Previous filing
16 May 2024
Next filing
10 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Options Exercise +233,333 +467% 283,333 31 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVRA Restricted Stock Unit Options Exercise $0 -233,333 -33% $0.000000 466,667 31 Jan 2025 Common Stock 233,333 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.